2025 ACCP Virtual Journal Club Webinar: Examining the Impact of Diet-and-Exercise-Induced Weight Loss on Drug Metabolism and Gastric Emptying in Patients with Obesity - LIVE

Live Session: Thursday, October 9^th, 2025, from 12:00 to 1:00 PM ET

On Demand: October 9^th, 2025 to October 9^th, 2028

Why is this webinar important to your practice? 

This webinar will increase learner knowledge of the effects of diet-and-exercise-induced weight loss on drug-metabolizing enzymes and gastric emptying in patients with obesity. The program will cover drug metabolizing enzymes are affected by diet-and-exercise-induced weight loss in patients with obesity. Learners that complete this webinar will recognize patients with obesity can have lower CYP1A2, CYP2C19, and CYP3A4 activity that counterintuitively implies the need for lower doses of drugs metabolized by these pathways.

Target Audience:

Interprofessional team of Physicians, Pharmacists, PhDs and other healthcare professionals interested in the impact of diet & exercise-induced weight loss on patients with obesity.

Learning Objectives

After completing this activity, the learner will be able to:

1. List at least one cytochrome (CYP) enzyme whereby activity increased after weight loss;
2. Define the parameter used to assess gastric emptying time;
3. Identify at least one single time point metabolic ratio that correlated with exposure (AUC) ratio.